http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105348219-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4b1eac93fa8426bfd541c9e14e11860
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
filingDate 2014-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be47b397bf670fc8bf3312ed094a3d6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7ad5c048276e298ebbdd136fd228e15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64e7c7a350c9006c68e1b27eaa8d957d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08c402d877dc68092cad2d02fb43d67a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1fbb62b686e9803cbddb7997076740b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31fc2842832022b6f5863709f8de955a
publicationDate 2016-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105348219-A
titleOfInvention Curcumin analogue and its preparation and application
abstract The invention belongs to the technical field of medicine, and relates to the preparation and application of a series of curcumin analogues, which have structures such as formula I, formula II and formula III, wherein R, R 1 and R 2 are as described in the specification. The pharmaceutically acceptable salts and solvates of the curcumin analogues, as well as the medicines containing the curcumin analogues or pharmaceutically acceptable salts thereof as active ingredients, can be used for treating cancer. The curcumin analogs and their medicinal salts described in the invention have good anticancer activity, and the preparation method is simple, feasible and easy to operate.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110229056-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109942395-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110025784-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106243152-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109942395-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111349057-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018077958-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019523227-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110229056-A
priorityDate 2014-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103848747-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468273630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467143462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466159724

Total number of triples: 42.